These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29763897)

  • 41. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome.
    Ullah K; Ur Rahman T; Wu DD; Lin XH; Liu Y; Guo XY; Leung PCK; Zhang RJ; Huang HF; Sheng JZ
    Clin Chim Acta; 2017 Aug; 471():243-247. PubMed ID: 28624500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
    Carmina E; Fruzzetti F; Lobo RA
    Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.
    Corenblum B; Taylor PJ
    Fertil Steril; 1982 Nov; 38(5):549-52. PubMed ID: 6813147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst) in Polycystic Ovary Syndrome (PCOS).
    Swaroop A; Jaipuriar AS; Gupta SK; Bagchi M; Kumar P; Preuss HG; Bagchi D
    Int J Med Sci; 2015; 12(10):825-31. PubMed ID: 26516311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome.
    Mu L; Pan J; Yang L; Chen Q; Chen Y; Teng Y; Wang P; Tang R; Huang X; Chen X; Yang H
    Reprod Biol Endocrinol; 2018 Oct; 16(1):104. PubMed ID: 30359269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of ghrelin/obestatin ratio in adolescence with polycystic ovarian syndrome.
    Wu W; Fan X; Yu Y; Wang Z; Wang Y
    Gynecol Endocrinol; 2018 Jan; 34(1):36-39. PubMed ID: 28649890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y
    Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma luteinizing hormone level affects the brain activity of patients with polycystic ovary syndrome.
    Lai W; Li X; Zhu H; Zhu X; Tan H; Feng P; Chen L; Luo C
    Psychoneuroendocrinology; 2020 Feb; 112():104535. PubMed ID: 31841986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
    Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment.
    Wiser A; Shehata F; Holzer H; Hyman JH; Shalom-Paz E; Son WY; Tulandi T
    J Reprod Med; 2013; 58(5-6):219-23. PubMed ID: 23763006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
    Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma level of calcitonin gene-related peptide in patients with polycystic ovary syndrome and its relationship to hormonal and metabolic parameters.
    Zhang Z; Gong F; Lu GX
    Peptides; 2012 Apr; 34(2):343-8. PubMed ID: 22314079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of anthropometric measurements on abnormal gonadotropin secretion in women with polycystic ovary syndrome.
    Haider S; Mannan N; Khan A; Qureshi MA
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):463-6. PubMed ID: 25052966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.